Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05429502
Title Study of Efficacy and Safety of Ribociclib (LEE011) in Combination With Topotecan and Temozolomide (TOTEM) in Pediatric Patients With Relapsed or Refractory Neuroblastoma and Other Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | child
Covered Countries USA | ITA | FRA | ESP | DEU | AUS

Facility Status City State Zip Country Details
Dana Farber Cancer Institute . RECRUITING Boston Massachusetts 02115 United States Details
St Jude s Childrens Research Hospital Dept of Regulatory RECRUITING Memphis Tennessee 38105-2794 United States Details
Novartis Investigative Site RECRUITING Randwick New South Wales 2130 Australia Details
Novartis Investigative Site RECRUITING Villejuif 94800 France Details
Novartis Investigative Site RECRUITING Koeln 50937 Germany Details
Novartis Investigative Site RECRUITING Milano MI 20133 Italy Details
Novartis Investigative Site RECRUITING Singapore 119074 Singapore Details
Novartis Investigative Site RECRUITING Singapore 229899 Singapore Details
Novartis Investigative Site RECRUITING Barcelona Catalunya 08035 Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field